Education
About Us
Working with TipRanks
Follow Us
RegeneRx Biopharmaceuticals (RGRX)
OTHER OTC:RGRX
Total Valuation
RegeneRx Biopharmaceuticals has a market cap or net worth of $449.00. The enterprise value is $1.16M.
Market Cap$449.00
Enterprise Value$1.16M
Share Statistics
RegeneRx Biopharmaceuticals has 1,496,966 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,496,966
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
RegeneRx Biopharmaceuticals’s return on equity (ROE) is 0.50 and return on invested capital (ROIC) is 1654.75%.
Return on Equity (ROE)0.50
Return on Assets (ROA)-4.52
Return on Invested Capital (ROIC)1654.75%
Return on Capital Employed (ROCE)8.18
Revenue Per Employee38.38K
Profits Per Employee-863.73K
Employee Count2
Asset Turnover0.20
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of RegeneRx Biopharmaceuticals is ―. RegeneRx Biopharmaceuticals’s PEG ratio is -0.16.
PE Ratio―
PS Ratio25975.55
PB Ratio-578.70
Price to Fair Value-578.70
Price to FCF-2.12K
Price to Operating Cash Flow-0.05
PEG Ratio-0.16
Income Statement
In the last 12 months, RegeneRx Biopharmaceuticals had revenue of 76.76K and earned -1.73M in profits. Earnings per share was -1.00.
Revenue76.76K
Gross Profit76.76K
Operating Income-1.40M
Pretax Income-1.73M
Net Income-1.73M
EBITDA-1.40M
Earnings Per Share (EPS)-1.00
Cash Flow
In the last 12 months, operating cash flow was -823.75K and capital expenditures 0.00, giving a free cash flow of -823.75K billion.
Operating Cash Flow-823.75K
Free Cash Flow-823.75K
Free Cash Flow per Share-0.55
Dividends & Yields
RegeneRx Biopharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta79.94
52-Week Price Change33.33%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)205.00
Important Dates
RegeneRx Biopharmaceuticals upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
RegeneRx Biopharmaceuticals as a current ratio of 0.55, with Debt / Equity ratio of -41.98%
Current Ratio0.55
Quick Ratio0.55
Debt to Market Cap<0.01
Net Debt to EBITDA-0.82
Interest Coverage Ratio-4.31
Taxes
In the past 12 months, RegeneRx Biopharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
RegeneRx Biopharmaceuticals EV to EBITDA ratio is -1.42K, with an EV/FCF ratio of -2.12K.
EV to Sales25.99K
EV to EBITDA-1.42K
EV to Free Cash Flow-2.12K
EV to Operating Cash Flow-2.12K
Balance Sheet
RegeneRx Biopharmaceuticals has $101.56K in cash and marketable securities with $1.49M in debt, giving a net cash position of -$1.39M billion.
Cash & Marketable Securities$101.56K
Total Debt$1.49M
Net Cash-$1.39M
Net Cash Per Share-$0.93
Tangible Book Value Per Share-$0.02
Margins
Gross margin is 100.00%, with operating margin of -1826.45%, and net profit margin of -2249.84%.
Gross Margin100.00%
Operating Margin-1826.45%
Pretax Margin-2249.84%
Net Profit Margin-2249.84%
EBITDA Margin-1826.21%
EBIT Margin-1826.45%
Analyst Forecast
The average price target for RegeneRx Biopharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―